Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 2005 Apr;90(4):338–341. doi: 10.1136/adc.2004.052720

DT5aP-Hib-IPV and MCC vaccines: preterm infants' response to accelerated immunisation

M Slack 1, S Cade 1, D Schapira 1, R Thwaites 1, A Crowley-Luke 1, J Southern 1, R Borrow 1, E Miller 1
PMCID: PMC1720330  PMID: 15781918

Abstract

Aims: To describe the immune response of preterm infants to combined diphtheria/tetanus/5 component acellular pertussis-Haemophilus influenzae type b inactivated polio vaccine (DT5aP-Hib-IPV) and meningococcal serogroup C conjugate vaccine (MCC) under accelerated schedule. To compare results with term infants immunised with DT5aP-Hib-IPV and with historical data from preterm infants immunised with a DT3 component aP-Hib vaccine.

Methods: Prospective observational study in preterm infants born at <32 weeks gestation with comparison to contemporary cohort of term infants. DT5aP-Hib-IPV and MCC vaccines were given at 2, 3, and 4 months.

Results: Fifty preterm infants (mean gestational age 28.5 weeks) completed the study. After three doses of vaccines Hib polysaccharide IgG geometric mean concentration (GMC) was 1.21 µg/ml with 80% ⩾0.15 µg/ml; MCC serum bactericidal assay geometric mean titre (GMT) was 1245 with 100% ⩾8. All infants achieved protective titres to diphtheria, tetanus, and the three poliovirus types with ⩾80% achieving protective rises in IgG against the five pertussis antigens.

Conclusion: Preterm infants immunised with DT5aP-Hib-IPV and MCC vaccines show IgG responses to Hib and MCC greater than seen historically in both term and preterm infants with a DT3aP-Hib vaccine, and for pertussis antigens and poliovirus type 1 responses similar to that seen in term infants immunised with DT5aP-Hib-IPV. Responses to poliovirus types 2 and 3 are reduced, but all infants achieved protective titres.

Full Text

The Full Text of this article is available as a PDF (99.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adenyi-Jones S. C., Faden H., Ferdon M. B., Kwong M. S., Ogra P. L. Systemic and local immune responses to enhanced-potency inactivated poliovirus vaccine in premature and term infants. J Pediatr. 1992 May;120(5):686–689. doi: 10.1016/s0022-3476(05)80228-8. [DOI] [PubMed] [Google Scholar]
  2. Bernbaum J. C., Daft A., Anolik R., Samuelson J., Barkin R., Douglas S., Polin R. Response of preterm infants to diphtheria-tetanus-pertussis immunizations. J Pediatr. 1985 Aug;107(2):184–188. doi: 10.1016/s0022-3476(85)80122-0. [DOI] [PubMed] [Google Scholar]
  3. Conway S., James J., Balfour A., Smithells R. Immunisation of the preterm baby. J Infect. 1993 Sep;27(2):143–150. doi: 10.1016/0163-4453(93)94674-z. [DOI] [PubMed] [Google Scholar]
  4. D'Angio C. T., Maniscalco W. M., Pichichero M. E. Immunologic response of extremely premature infants to tetanus, Haemophilus influenzae, and polio immunizations. Pediatrics. 1995 Jul;96(1 Pt 1):18–22. [PubMed] [Google Scholar]
  5. D'Angio C. T., Maniscalco W. M., Pichichero M. E. Immunologic response of extremely premature infants to tetanus, Haemophilus influenzae, and polio immunizations. Pediatrics. 1995 Jul;96(1 Pt 1):18–22. [PubMed] [Google Scholar]
  6. Dagan R., Eskola J., Leclerc C., Leroy O. Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants. Infect Immun. 1998 May;66(5):2093–2098. doi: 10.1128/iai.66.5.2093-2098.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Eskola J., Olander R. M., Hovi T., Litmanen L., Peltola S., Käyhty H. Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine. Lancet. 1996 Dec 21;348(9043):1688–1692. doi: 10.1016/S0140-6736(96)04356-5. [DOI] [PubMed] [Google Scholar]
  8. Goldblatt D., Richmond P., Millard E., Thornton C., Miller E. The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination. J Infect Dis. 1999 Aug;180(2):538–541. doi: 10.1086/314901. [DOI] [PubMed] [Google Scholar]
  9. Lee C. Y., Thipphawong J., Huang L. M., Lee P. I., Chiu H. H., Lin W., Debois H., Harrison D., Xie F., Barreto L. An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants. Pediatrics. 1999 Jan;103(1):25–30. doi: 10.1542/peds.103.1.25. [DOI] [PubMed] [Google Scholar]
  10. Linder N., Handsher R., German B., Sirota L., Bachman M., Zinger S., Mendelson E., Barzilai A. Controlled trial of immune response of preterm infants to recombinant hepatitis B and inactivated poliovirus vaccines administered simultaneously shortly after birth. Arch Dis Child Fetal Neonatal Ed. 2000 Jul;83(1):F24–F27. doi: 10.1136/fn.83.1.F24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. McVernon J., Andrews N., Slack M. P. E., Ramsay M. E. Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis. Lancet. 2003 May 3;361(9368):1521–1523. doi: 10.1016/s0140-6736(03)13171-6. [DOI] [PubMed] [Google Scholar]
  12. Olin P., Rasmussen F., Gustafsson L., Hallander H. O., Heijbel H. Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines. Lancet. 1997 Nov 29;350(9091):1569–1577. doi: 10.1016/s0140-6736(97)06508-2. [DOI] [PubMed] [Google Scholar]
  13. Ramsay M. E., Miller E., Ashworth L. A., Coleman T. J., Rush M., Waight P. A. Adverse events and antibody response to accelerated immunisation in term and preterm infants. Arch Dis Child. 1995 Mar;72(3):230–232. doi: 10.1136/adc.72.3.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Richmond P., Borrow R., Miller E., Clark S., Sadler F., Fox A., Begg N., Morris R., Cartwright K. Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory. J Infect Dis. 1999 Jun;179(6):1569–1572. doi: 10.1086/314753. [DOI] [PubMed] [Google Scholar]
  15. Shinefield Henry, Black Steven, Ray Paula, Fireman Bruce, Schwalbe Joan, Lewis Edwin. Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants. Pediatr Infect Dis J. 2002 Mar;21(3):182–186. doi: 10.1097/00006454-200203000-00003. [DOI] [PubMed] [Google Scholar]
  16. Slack M. H., Schapira D., Thwaites R. J., Burrage M., Southern J., Andrews N., Borrow R., Goldblatt D., Miller E. Immune response of premature infants to meningococcal serogroup C and combined diphtheria-tetanus toxoids-acellular pertussis-Haemophilus influenzae type b conjugate vaccines. J Infect Dis. 2001 Dec 3;184(12):1617–1620. doi: 10.1086/324666. [DOI] [PubMed] [Google Scholar]
  17. Slack M. H., Schapira D., Thwaites R. J., Schapira C., Bamber J., Burrage M., Southern J., Andrews N., Miller E. Acellular pertussis vaccine given by accelerated schedule: response of preterm infants. Arch Dis Child Fetal Neonatal Ed. 2004 Jan;89(1):F57–F60. doi: 10.1136/fn.89.1.F57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Smolen P., Bland R., Heiligenstein E., Lawless M. R., Dillard R., Abramson J. Antibody response to oral polio vaccine in premature infants. J Pediatr. 1983 Dec;103(6):917–919. doi: 10.1016/s0022-3476(83)80714-8. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES